1. Home
  2. STVN vs MMED Comparison

STVN vs MMED Comparison

Compare STVN & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$16.11

Market Cap

3.7B

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$12.33

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STVN
MMED
Founded
1949
1983
Country
Italy
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.1B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
STVN
MMED
Price
$16.11
$12.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$25.67
$22.56
AVG Volume (30 Days)
575.1K
829.2K
Earning Date
05-07-2026
06-03-2026
Dividend Yield
0.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.67
$15.99
Revenue Next Year
$9.99
$10.00
P/E Ratio
$27.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.89
$12.69
52 Week High
$28.00
$17.86

Technical Indicators

Market Signals
Indicator
STVN
MMED
Relative Strength Index (RSI) 62.69 33.71
Support Level $13.58 N/A
Resistance Level $16.69 $15.80
Average True Range (ATR) 0.75 0.89
MACD 0.22 -0.10
Stochastic Oscillator 69.79 0.86

Price Performance

Historical Comparison
STVN
MMED

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: